| Literature DB >> 35382520 |
Mislav Radic1,2,3, Tracy M Frech1.
Abstract
Since it was first used in 1997, the term "big data" has been popularized; however, the concept of big data is relatively new to medicine. Big data refers to a method and technique to systematically retrieve, collect, manage, and analyze very large and complex sets of structured and unstructured data that cannot be sufficiently processed using traditional methods of processing data. Integrating big data in rare diseases with low prevalence and incidence, like systemic sclerosis is of particular importance. We conducted a literature review of use of big data in systemic sclerosis. The volume of data on systemic sclerosis has grown steadily in the recent years; however, big data methods have not been readily used. This inexhaustible source of data needs to be used more to unleash its full potential.Entities:
Keywords: Systemic sclerosis; big data; methodology; rare diseases; registries
Year: 2020 PMID: 35382520 PMCID: PMC8922620 DOI: 10.1177/2397198320929805
Source DB: PubMed Journal: J Scleroderma Relat Disord ISSN: 2397-1983